Inducible or constitutive expression of resistance in clinical isolates of streptococci and enterococci cross-resistant to erythromycin and lincomycin

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 4, 1999, Pages 559-562

  Rosato, A ^a   Vicarini, H ^a   Leclercq, R ^a,b,c  

^a HENRI MONDOR HOSPITAL   (France)

^b CHU CÔTE DE NACRE   (France)

^c CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ERYTHROMYCIN; LINCOMYCIN; MACROLIDE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; ENTEROCOCCUS FAECALIS; GENE AMPLIFICATION; GENE DELETION; GENE DUPLICATION; GENE SEQUENCE; METHYLATION; NONHUMAN; STREPTOCOCCUS PNEUMONIAE;

EID: 0032931288     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.4.559     Document Type: Article

References (9)

1. Leclercq, R. & Courvalin, P. (1991). Bacterial resistance to macrolide, lincosamide and streptogramin antibiotics by target modification. Antimicrobial Agents and Chemotherapy 35, 1267-72.
2. Weisblum, B. (1995). Erythromycin resistance by ribosome modification. Antimicrobial Agents and Chemotherapy 39, 577-85.
3. Horinouchi, S., Byeon, W. & Weisblum, B. (1983). A complex attenuator regulates inducible resistance to macrolide, lincosamide, and streptogramin type B antibiotics in Streptococcus sanguis. Journal of Bacteriology 154, 1252-62.
4. Shaw, J. H. & Clewell, D. B. (1985). Complete nucleotide sequence of macrolide-lincosamide-streptogramin B resistance transposon Tn917 in Streptococcus faecalis. Journal of Bacteriology 164, 782-96.
5. Trieu-Cuot, P., Poyart-Salmeron, C., Carlier, C. & Courvalin, P. (1990). Nucleotide sequence of the erythromycin resistance gene of the conjugative transposon Tn1545. Nucleic Acids Research 18, 3660.
6. Martin, B., Alloing, G., Méjean, V. & Claverys, J. P. (1987). Constitutive expression of erythromycin resistance mediated by ermAM determinant of plasmid pAMβ1 results from deletion of 5′ leader peptide sequences. Plasmid 18, 250-3.
7. Rosato, A., Vicarini, H., Bonnefoy, A., Chantot, J. F. & Leclercq, R. (1998). A new ketolide, HMR 3004, active against streptococci inducibly resistant to erythromycin. Antimicrobial Agents and Chemotherapy 42, 1392-6.
8. Comité de l'Antibiogramme de la Société Française de Microbiologie. (1996). Technical recommendations for in vitro susceptibility testing. Clinical Microbiology and Infection 2, Suppl. 1, S11-S25.
9. Bonnefoy, A., Girard, A. M., Agouridas, C. & Chantot, J. F. (1997). Ketolides lack inducibility properties of MLS(B) resistance phenotype. Journal of Antimicrobial Chemotherapy 40, 85-90.